Ipha

Pharma body calls for more State funding on medicines

Government to save €15m this year as prices fall across 750 drugs

Price pressure keeps nine new drugs from Irish patients

Cancer drugs feature in list of therapies waiting HSE approval on cost grounds

Crunch meeting fails to agree funding for new medicines

Drug companies told there is no budget and no plans for supplementary health budget

Patients suffer as new drugs languish on Minister’s desk

Cantillon: while Orkambi has been approved, nine other vital drugs are stalled in system

Pfizer bounces back from Allergan setback by buying, buying, buying

The drug giant’s point man in Ireland talks about acquisitions, setbacks, prices and Trump

Pfizer cuts price of Enbrel to match rival ‘biosimilar’ drug

Price drop is first under pricing deal signed by Government and Irish Pharmaceutical Healthcare Association

Price deal on medicines to save State €140m in first year

Annual savings of €78.4m predicted as result of agreement with drugs manufacturers

Biosimilar drugs win backing in landmark patient study

Drug manufacturers’ lobby group Ipha urges caution over study of competing treatments

‘Biosimilar blocker’ clause could cost HSE over €50m a year

Providers of branded patent drugs and generics face off over provison in draft agreement on drug prices

Most Read

1

Different Strokes: Ewen Ferguson gets the last laugh as ISPS Handa World Invitational win silences Twitter troll

2

New Intel filtration system to save almost half a billion litres of water a year

3

Ireland’s Rhasidat Adeleke breaks Irish record as she finishes fifth in European 400m final

4

London mobility scooter stabbing victim named as Irishman Thomas O’Halloran (87)

5

Indian multinational Tech Mahindra establishes new Irish-based design agency, creating 40 jobs

You may also like...

The Irish Times ePaper